OOIR: Observatory of International Research

Papers

(The TQCC of Hypertension is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
2020 International Society of Hypertension Global Hypertension Practice Guidelines	1887
Renin-Angiotensin System Blockers and the COVID-19 Pandemic	365
Age and Multimorbidity Predict Death Among COVID-19 Patients	306
Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension	239
Blood Pressure and Risks of Cognitive Impairment and Dementia	177
Evidence and Recommendations on the Use of Telemedicine for the Management of Arterial Hypertension	176
Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association	169
May Measurement Month 2019	159
Interaction of SARS-CoV-2 and Other Coronavirus With ACE (Angiotensin-Converting Enzyme)-2 as Their Main Receptor	140
Hypertension Pharmacological Treatment in Adults: A World Health Organization Guideline Executive Summary	139
Trimethylamine-N-Oxide Promotes Age-Related Vascular Oxidative Stress and Endothelial Dysfunction in Mice and Healthy Humans	135
Racial/Ethnic Disparities in Hypertension Prevalence, Awareness, Treatment, and Control in the United States, 2013 to 2018	132
Management of Hypertension in the Digital Era	125
Subtypes of Preeclampsia: Recognition and Determining Clinical Usefulness	119
Adherence to Single-Pill Versus Free-Equivalent Combination Therapy in Hypertension	114
Redefining Cardiac Biomarkers in Predicting Mortality of Inpatients With COVID-19	110
Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension	104
Early and Supernormal Vascular Aging	101
Endothelium-Macrophage Crosstalk Mediates Blood-Brain Barrier Dysfunction in Hypertension	100
Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease	99
ACE2 (Angiotensin-Converting Enzyme 2), COVID-19, and ACE Inhibitor and Ang II (Angiotensin II) Receptor Blocker Use During the Pandemic	96
Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association	95
Antihypertensive Drugs and COVID-19 Risk	93
Discrimination and Hypertension Risk Among African Americans in the Jackson Heart Study	93
Evaluation of the Accuracy of Cuffless Blood Pressure Measurement Devices: Challenges and Proposals	92

Prediction of Preeclampsia-Related Adverse Outcomes With the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor)-Ratio in the Clinical Routine	81
Association of Cardiovascular Risk Factors and Lifestyle Behaviors With Hypertension	78
Weight-Loss Strategies for Prevention and Treatment of Hypertension: A Scientific Statement From the American Heart Association	78
Urate, Blood Pressure, and Cardiovascular Disease	77
Blood Pressure Control Among US Adults, 2009 to 2012 Through 2017 to 2020	71
Microbial Peer Pressure	68
Machine Learning Strategy for Gut Microbiome-Based Diagnostic Screening of Cardiovascular Disease	68
Pathophysiology of Diuretic Resistance and Its Implications for the Management of Chronic Heart Failure	67
SGLT2 Inhibition via Empagliflozin Improves Endothelial Function and Reduces Mitochondrial Oxidative Stress: Insights From Frail Hypertensive and Diabetic Patients	67
Nonvalidated Home Blood Pressure Devices Dominate the Online Marketplace in Australia	67
Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study	66
Polygenic Risk Scores Predict Hypertension Onset and Cardiovascular Risk	66
Epithelial Sodium Channel and Salt-Sensitive Hypertension	65
COVID-19	64
SPARTE Study: Normalization of Arterial Stiffness and Cardiovascular Events in Patients With Hypertension at Medium to Very High Risk	64
Influence of Sex and Age on Muscle Sympathetic Nerve Activity of Healthy Normotensive Adults	62
Animal Models of Preeclampsia	60
Gnotobiotic Rats Reveal That Gut Microbiota Regulates Colonic mRNA of Ace2 , the Receptor for SARS-CoV-2 Infectivity	60
Blood Pressure and Risk of Cardiovascular Disease in UK Biobank	60
Modest Sodium Reduction Increases Circulating Short-Chain Fatty Acids in Untreated Hypertensives	60
ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases	59
Effect of KBP-5074 on Blood Pressure in Advanced Chronic Kidney Disease: Results of the BLOCK-CKD Study	59
Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination	58
Physical Activity as a Critical Component of First-Line Treatment for Elevated Blood Pressure or Cholesterol: Who, What, and How?: A Scientific Statement From the American Heart Association	58
Visit-to-Visit Blood Pressure Variability Is Associated With Cognitive Decline and Incident Dementia	57
Redox Regulation of Cardiac ASK1 (Apoptosis Signal-Regulating Kinase 1) Controls p38-MAPK (Mitogen-Activated Protein Kinase) and Orchestrates Cardiac Remodeling to Hypertension	57
Plasma Angiotensin Peptide Profiling and ACE (Angiotensin-Converting Enzyme)-2 Activity in COVID-19 Patients Treated With Pharmacological Blockers of the Renin-Angiotensin System	57
Pulmonary Hypertension Due to Left Heart Disease	56
Hypertension, Prehypertension, and Hypertension Control	56
Relationship Between Blood Pressure and Incident Cardiovascular Disease: Linear and Nonlinear Mendelian Randomization Analyses	56
Impact of the Vulnerable Preterm Heart and Circulation on Adult Cardiovascular Disease Risk	56
Neuronal Networks in Hypertension	54
Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence Testing	54
Endothelial FGFR1 (Fibroblast Growth Factor Receptor 1) Deficiency Contributes Differential Fibrogenic Effects in Kidney and Heart of Diabetic Mice	54
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: a Review of Shared Cardiometabolic Risk Factors	53
Effect of Intensive Blood Pressure Lowering on the Risk of Atrial Fibrillation	53
Association Between Blood Pressure Variability With Dementia and Cognitive Impairment: A Systematic Review and Meta-Analysis	53
Role of Klotho in the Development of Essential Hypertension	53
Primordial Prevention of High Blood Pressure in Childhood	53
Mitochondrial Fission Mediates Endothelial Inflammation	52
Ambulatory Blood Pressure Monitoring in Children and Adolescents: 2022 Update: A Scientific Statement From the American Heart Association	52
Hypertension Control in the United States 2009 to 2018: Factors Underlying Falling Control Rates During 2015 to 2018 Across Age- and Race-Ethnicity Groups	52
Racial Disparities in Cardiovascular Complications With Pregnancy-Induced Hypertension in the United States	52
Maternal Treatment With Captopril Persistently Alters Gut-Brain Communication and Attenuates Hypertension of Male Offspring	52
Aldosterone as a Mediator of Cardiovascular Damage	51
Circadian Rhythm, Clock Genes, and Hypertension: Recent Advances in Hypertension	51
Albuminuria Testing in Hypertension and Diabetes: An Individual-Participant Data Meta-Analysis in a Global Consortium	50
Heart Failure in Women With Hypertensive Disorders of Pregnancy	50
Aortic Pulse Wave Velocity Predicts Cardiovascular Events and Mortality in Patients Undergoing Coronary Angiography	50
Ambulatory Blood Pressure Monitoring to Diagnose and Manage Hypertension	50

Intraindividual Variability of Aldosterone Concentrations in Primary Aldosteronism	50
Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries	49
Clinical Features of COVID-19 in Patients With Essential Hypertension and the Impacts of Renin-angiotensin-aldosterone System Inhibitors on the Prognosis of COVID-19 Patients	49
Regional Patterns and Association Between Obesity and Hypertension in Africa	49
Gut Microbiome-Derived Metabolite Trimethylamine N-Oxide Induces Aortic Stiffening and Increases Systolic Blood Pressure With Aging in Mice and Humans	49
Orthostatic Hypertension	49
T2* Placental Magnetic Resonance Imaging in Preterm Preeclampsia	48
Management of Stage 1 Hypertension in Adults With a Low 10-Year Risk for Cardiovascular Disease: Filling a Guidance Gap: A Scientific Statement From the American Heart Association	48
Worldwide Trends in Prevalence, Mortality, and Disability-Adjusted Life Years for Hypertensive Heart Disease From 1990 to 2017	48
Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality	48
Arterial Stiffness and Long-Term Risk of Health Outcomes: The Framingham Heart Study	48
Symptom Recognition Is Impaired in Patients With Orthostatic Hypotension	47
Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia	47
Antihypertensive Drugs and Risk of Depression	47
New Concept of Onco-Hypertension and Future Perspectives	46
Microbiota Introduced to Germ-Free Rats Restores Vascular Contractility and Blood Pressure	46
Effects of Chronic Nicotine Inhalation on Systemic and Pulmonary Blood Pressure and Right Ventricular Remodeling in Mice	46
Data Sharing Under the General Data Protection Regulation	46
Short-Term Postpartum Blood Pressure Self-Management and Long-Term Blood Pressure Control: A Randomized Controlled Trial	45
Hypertension, Neurovascular Dysfunction, and Cognitive Impairment	45
Presence of Subclinical Hypercortisolism in Clinical Aldosterone-Producing Adenomas Predicts Lower Clinical Success	45
Serum Aldosterone Concentration, Blood Pressure, and Coronary Artery Calcium	45
Dietary Approaches to Stop Hypertension Dietary Intervention Improves Blood Pressure and Vascular Health in Youth With Elevated Blood Pressure	45
Association of Cumulative Systolic Blood Pressure With Long-Term Risk of Cardiovascular Disease and Healthy Longevity	45
Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System	45
Maternal Hypertensive Pregnancy Disorders and Mental Disorders in Children	45
Cardiovascular Event Risks Associated With Masked Nocturnal Hypertension Defined by Home Blood Pressure Monitoring in the J-HOP Nocturnal Blood Pressure Study	45
Butyrate Regulates COVID-19–Relevant Genes in Gut Epithelial Organoids From Normotensive Rats	45
Upregulation of Piezo1 (Piezo Type Mechanosensitive Ion Channel Component 1) Enhances the Intracellular Free Calcium in Pulmonary Arterial Smooth Muscle Cells From Idiopathic Pulmonary Arterial Hypert	45
Exposure to Particulate Matter Is Associated With Elevated Blood Pressure and Incident Hypertension in Urban India	44
Uric Acid and Hypertension: a Review of Evidence and Future Perspectives for the Management of Cardiovascular Risk	44
Blood-Brain Barrier Crossing Renin-Angiotensin Drugs and Cognition in the Elderly: A Meta-Analysis	44
Impact of Arterial Stiffness on All-Cause Mortality in Patients Hospitalized With COVID-19 in Spain	44
Association of Hypertension and Blood Pressure With Kidney Cancer Risk	44
Reference Intervals for Brachial Artery Flow-Mediated Dilation and the Relation With Cardiovascular Risk Factors	44
Piezo1-Mediated Mechanotransduction Promotes Cardiac Hypertrophy by Impairing Calcium Homeostasis to Activate Calpain/Calcineurin Signaling	44
Trends in Hypertension-Related Cardiovascular Mortality in the United States, 2000 to 2018	43
Microcirculation and Macrocirculation in Hypertension: A Dangerous Cross-Link?	42
Trends in Worldwide Research in Hypertension Over the Period 1999–2018	42
Long-Term Cardiovascular Disease Risk in Women After Hypertensive Disorders of Pregnancy: Recent Advances in Hypertension	42
Ca ²⁺ -Dependent NOX5 (NADPH Oxidase 5) Exaggerates Cardiac Hypertrophy Through Reactive Oxygen Species Production	42
Essential Hypertension Is Associated With Changes in Gut Microbial Metabolic Pathways: A Multisite Analysis of Ambulatory Blood Pressure	42
Gut Pathology and Its Rescue by ACE2 (Angiotensin-Converting Enzyme 2) in Hypoxia-Induced Pulmonary Hypertension	41
High HDL (High-Density Lipoprotein) Cholesterol Increases Cardiovascular Risk in Hypertensive Patients	41
Gut Microbiota Profile Identifies Transition From Compensated Cardiac Hypertrophy to Heart Failure in Hypertensive Rats	41
Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in US Adults Across Blood Pressure Categories	40
Does Estimated Pulse Wave Velocity Add Prognostic Information?	40
Effects of Arterial Stiffness and Carotid Intima-Media Thickness Progression on the Risk of Overweight/Obesity and Elevated Blood Pressure/Hypertension: a Cross-Lagged Cohort Study	39
Arterial Stiffness in Aging: Does It Have a Place in Clinical Practice?	39
Brain Functional Magnetic Resonance Imaging Highlights Altered Connections and Functional Networks in Patients With Hypertension	39
Clinical and Proteomic Correlates of Plasma ACE2 (Angiotensin-Converting Enzyme 2) in Human Heart Failure	39
Association Between Blood Pressure Control and Coronavirus Disease 2019 Outcomes in 45 418 Symptomatic Patients With Hypertension	39
Mesenchymal Stem Cell–Derived Extracellular Vesicles Induce Regulatory T Cells to Ameliorate Chronic Kidney Injury	39
Subclinical Systolic and Diastolic Dysfunction Is Evident in Youth With Elevated Blood Pressure	39
Effects of Home Particulate Air Filtration on Blood Pressure	39
Effect of Sleep Disturbances on Blood Pressure	38
Nocturnal Hypertension and Heart Failure: Mechanisms, Evidence, and New Treatments	38
Primary Aldosteronism Decreases Insulin Secretion and Increases Insulin Clearance in Humans	38
Blood Pressure Effects of Gender-Affirming Hormone Therapy in Transgender and Gender-Diverse Adults	38
Digital Therapeutics in Hypertension: Evidence and Perspectives	38
Single-Center Prospective Cohort Study on the Histopathology, Genotype, and Postsurgical Outcomes of Patients With Primary Aldosteronism	37
Nitric Oxide-cGMP Signaling in Hypertension	37
Retinal Vessel Diameters and Blood Pressure Progression in Children	36
Associations Between Systolic Interarm Differences in Blood Pressure and Cardiovascular Disease Outcomes and Mortality	36
Developmental and Early Life Origins of Cardiometabolic Risk Factors	36
Pediatric and Adult Ambulatory Blood Pressure Thresholds and Blood Pressure Load as Predictors of Left Ventricular Hypertrophy in Adolescents	36
Renin-Angiotensin-Aldosterone System Inhibitors and Risks of Severe Acute Respiratory Syndrome Coronavirus 2 Infection	36
Concerns on the Specificity of Commercial ELISAs for the Measurement of Angiotensin (1–7) and Angiotensin II in Human Plasma	36
Genetics of Primary Aldosteronism	36
Value of a Machine Learning Approach for Predicting Clinical Outcomes in Young Patients With Hypertension	35
Inverse Association Between Riboflavin Intake and New-Onset Hypertension	35
Postnatal Enalapril to Improve Cardiovascular Function Following Preterm Preeclampsia (PICk-UP):	34
Cancer Therapy–Related Hypertension: A Scientific Statement From the American Heart Association	34
Metabolites and Hypertension: Insights into Hypertension as a Metabolic Disorder	34
Left Atrioventricular Coupling Index as a Prognostic Marker of Cardiovascular Events: The MESA Study	34
Caspase-4/11–Mediated Pulmonary Artery Endothelial Cell Pyroptosis Contributes to Pulmonary Arterial Hypertension	34
Effect and Acceptability of Mindfulness-Based Stress Reduction Program on Patients With Elevated Blood Pressure or Hypertension	34
Hypertension, Arterial Stiffness, and Diabetes: a Prospective Cohort Study	34
Endothelial Sphingolipid De Novo Synthesis Controls Blood Pressure by Regulating Signal Transduction and NO via Ceramide	34
Association Between the European Society of Cardiology/European Society of Hypertension Heart Rate Thresholds for Cardiovascular Risk and Neuroadrenergic Markers	34

The Association of Age at Diagnosis of Hypertension With Brain Structure and Incident Dementia in the UK Biobank	34
Blood Pressure Classification of 2017 Associated With Cardiovascular Disease and Mortality in Young Chinese Adults	34
Preconception Blood Pressure and Its Change Into Early Pregnancy	33
Obstructive Sleep Apnea–Induced Neurogenic Nocturnal Hypertension	33
Direct Comparison of Home Versus Ambulatory Defined Nocturnal Hypertension for Predicting Cardiovascular Events	33
Effect of Arterial Stiffness and Carotid Intima-Media Thickness Progression on the Risk of Dysglycemia, Insulin Resistance, and Dyslipidemia: a Temporal Causal Longitudinal Study	33
Isolated Diastolic Hypertension in the UK Biobank	33
White-Coat Hypertension: Pathophysiological and Clinical Aspects: Excellence Award for Hypertension Research 2020	33
Chemokine Receptor CXCR-2 Initiates Atrial Fibrillation by Triggering Monocyte Mobilization in Mice	33
Urinary- and Plasma-Derived Exosomes Reveal a Distinct MicroRNA Signature Associated With Albuminuria in Hypertension	33
Confounding Factors in Renal Denervation Trials	33
Variations in Cardiovascular Structure, Function, and Geometry in Midlife Associated With a History of Hypertensive Pregnancy	33
Dietary Carbohydrate Intake and New-Onset Hypertension: A Nationwide Cohort Study in China	33
Multi-Fetal Pregnancy, Preeclampsia, and Long-Term Cardiovascular Disease	33
Association Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection in South Korea	33
Blood Pressure Control and Dementia Risk in Midlife Patients With Atrial Fibrillation	33
ACE (Angiotensin-Converting Enzyme) Inhibitors/Angiotensin Receptor Blockers Are Associated With Lower Colorectal Cancer Risk	33
Angiotensin II Type 2 Receptor: A Target for Protection Against Hypertension, Metabolic Dysfunction, and Organ Remodeling	32
Greater T Regulatory Cells in Females Attenuate DOCA-Salt–Induced Increases in Blood Pressure Versus Males	32
Origins of Primary Hypertension in Children	32
Immune System and Microvascular Remodeling in Humans	32
Identification, Heritability, and Relation With Gene Expression of Novel DNA Methylation Loci for Blood Pressure	32
Initial Estimated Glomerular Filtration Rate Decline and Long-Term Renal Function During Intensive Antihypertensive Therapy	32
Cardiovascular End Points and Mortality Are Not Closer Associated With Central Than Peripheral Pulsatile Blood Pressure Components	32
Prediction of Cardiovascular Events by Type I Central Systolic Blood Pressure	31
Screening Rates for Primary Aldosteronism Among Individuals With Hypertension Plus Hypokalemia: A Population-Based Retrospective Cohort Study	31
Increased Arterial Stiffness Amplifies the Association Between Home Blood Pressure Variability and Cardiac Overload	31
Microdissection of the Human Renal Nervous System	31
Endogenous Activation of Glucagon-Like Peptide-1 Receptor Contributes to Blood Pressure Control	31
Role of Extracellular Vesicles in the Pathogenesis of Vascular Damage	30
Changes in Blood Pressure Outcomes Among Hypertensive Individuals During the COVID-19 Pandemic: A Time Series Analysis in Three US Healthcare Organizations	30
Validation Study to Determine the Accuracy of Central Blood Pressure Measurement Using the Sphygmocor Xcel Cuff Device	30
PlGF (Placental Growth Factor) Testing in Clinical Practice: Evidence From a Canadian Tertiary Maternity Referral Center	30
Furosemide for Accelerated Recovery of Blood Pressure Postpartum in Women with a Hypertensive Disorder of Pregnancy	30
Association Between Periodontitis and Blood Pressure Highlighted in Systemically Healthy Individuals	30
Immunosuppression of Macrophages Underlies the Cardioprotective Effects of CST (Catestatin)	30
Individualized Beta-Blocker Treatment for High Blood Pressure Dictated by Medical Comorbidities: Indications Beyond the 2018 European Society of Cardiology/European Society of Hypertension Guidelines	29
Precise Mapping of Intra-Adrenal Aldosterone Activities Provides a Novel Surgical Strategy for Primary Aldosteronism	29
Associations of Arterial Stiffness With Cognitive Performance, and the Role of Microvascular Dysfunction	29
Mid to Late Life Hypertension Trends and Cerebral Small Vessel Disease in the Framingham Heart Study	29
Percutaneous Intracoronary Delivery of Plasma Extracellular Vesicles Protects the Myocardium Against Ischemia-Reperfusion Injury in Canis	28
Adherence to Antihypertensive Medication and Incident Cardiovascular Events in Young Adults With Hypertension	28
Preeclamptic Women Have Decreased Circulating IL-10 (Interleukin-10) Values at the Time of Preeclampsia Diagnosis	28
Aortic Stiffness, Central Blood Pressure, and Pulsatile Arterial Load Predict Future Thoracic Aortic Aneurysm Expansion	28
Megalin	28
Is the KDIGO Systolic Blood Pressure Target <120 mm Hg for Chronic Kidney Disease Appropriate in Routine Clinical Practice?	27
FGF12 (Fibroblast Growth Factor 12) Inhibits Vascular Smooth Muscle Cell Remodeling in Pulmonary Arterial Hypertension	27
Hypertension-Mediated Organ Damage: Prevalence, Correlates, and Prognosis in the Community	27
Blood Pressure Levels and Risks of Dementia: a Nationwide Study of 4.5 Million People	27
Role of Microparticles in Cardiovascular Disease: Implications for Endothelial Dysfunction, Thrombosis, and Inflammation	27
Pulse Pressure, Prognosis, and Influence of Sacubitril/Valsartan in Heart Failure With Preserved Ejection Fraction	27
Twenty-Four–Hour Urinary Sodium and Potassium Excretion and Their Associations With Blood Pressure Among Adults in China	27
The 2020 “WHO Technical Specifications for Automated Non-Invasive Blood Pressure Measuring Devices With Cuff”	27
Site-1 Protease-Derived Soluble (Pro)Renin Receptor Contributes to Angiotensin II–Induced Hypertension in Mice	27
Altered Airway Microbiota Composition in Patients With Pulmonary Hypertension	27
Myeloid Piezo1 Deletion Protects Renal Fibrosis by Restraining Macrophage Infiltration and Activation	27
Cellular Senescence	27
Mineralocorticoid Receptor Antagonists for Hypertension Management in Advanced Chronic Kidney Disease	26
Missing Verification of Source Data in Hypertension Research: The HYGIA PROJECT in Perspective	25
AT2R’s (Angiotensin II Type 2 Receptor’s) Role in Cognitive and Cerebrovascular Deficits in a Mouse Model of Alzheimer Disease	25
Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes	25
Markers of Focal and Diffuse Nonischemic Myocardial Fibrosis Are Associated With Adverse Cardiac Remodeling and Prognosis in Patients With Hypertension: The REMODEL Study	25
Machine Learning Clustering for Blood Pressure Variability Applied to Systolic Blood Pressure Intervention Trial (SPRINT) and the Hong Kong Community Cohort	25
Do β-Blockers Cause Depression?	25
Per- and Polyfluoroalkyl Substances and Incident Hypertension in Multi-Racial/Ethnic Women: The Study of Women's Health Across the Nation	25
NOX4/H ₂ O ₂ /mTORC1 Pathway in Salt-Induced Hypertension and Kidney Injury	25
Epigenetic Regulation of KL (Klotho) via H3K27me3 (Histone 3 Lysine [K] 27 Trimethylation) in Renal Tubule Cells	24
Effects of Experimental Sleep Restriction on Ambulatory and Sleep Blood Pressure in Healthy Young Adults: A Randomized Crossover Study	24
Activation of Rac1-Mineralocorticoid Receptor Pathway Contributes to Renal Injury in Salt-Loadeddb/dbMice	24
Cumulative Blood Pressure Exposure, Basal Ganglia, and Thalamic Morphology in Midlife	24
Maternal and Perinatal Outcomes of White Coat Hypertension During Pregnancy	24
How to Improve Awareness, Treatment, and Control of Hypertension in Africa, and How to Reduce Its Consequences: A Call to Action From the World Hypertension League	24
Magnesium Supplementation Attenuates Pulmonary Hypertension via Regulation of Magnesium Transporters	24
Toward Precision Medicine: Circadian Rhythm of Blood Pressure and Chronotherapy for Hypertension - 2021 NHLBI Workshop Report	24
Hypertension Burden and the Risk of New-Onset Atrial Fibrillation	24
Platelets Promote Ang II (Angiotensin II)-Induced Atrial Fibrillation by Releasing TGF-β1 (Transforming Growth Factor-β1) and Interacting With Fibroblasts	24
Lowering Nighttime Blood Pressure With Bedtime Dosing of Antihypertensive Medications: Controversies in Hypertension - Con Side of the Argument	24
Primary Cilia in Trophoblastic Cells	24
IL-18 (Interleukin-18) Produced by Renal Tubular Epithelial Cells Promotes Renal Inflammation and Injury During Deoxycorticosterone/Salt-Induced Hypertension in Mice	23
Antihypertensive Treatment in Elderly Frail Patients	23
Performance of Confirmatory Tests for Diagnosing Primary Aldosteronism: a Systematic Review and Meta-Analysis	23
Clinical Applicability of Monitoring Antihypertensive Drug Levels in Blood	23
Single-Nucleus RNA Sequencing of the Hypothalamic Arcuate Nucleus of C57BL/6J Mice After Prolonged Diet-Induced Obesity	23
Early-but Not Late-Onset Hypertension Is Related to Midlife Cognitive Function	23
New Noninvasive Methods to Evaluate Microvascular Structure and Function	23
l -Tryptophan–Induced Vasodilation Is Enhanced in Preeclampsia	23
Proximal Tubule-Specific Deletion of Angiotensin II Type 1a Receptors in the Kidney Attenuates Circulating and Intratubular Angiotensin II–Induced Hypertension in PT- Agtr1a	23
Blood Pressure and Angiogenic Markers in Pregnancy	23
Association of Fatal and Nonfatal Cardiovascular Outcomes With 24-Hour Mean Arterial Pressure	23
Effects of Ramipril on the Aldosterone/Renin Ratio and the Aldosterone/Angiotensin II Ratio in Patients With Primary Aldosteronism	23
Inorganic Nitrite Supplementation Improves Endothelial Function With Aging	23
Folic Acid Supplement Use and Increased Risk of Gestational Hypertension	23
STEAP3 (Six-Transmembrane Epithelial Antigen of Prostate 3) Inhibits Pathological Cardiac Hypertrophy	23
Angiogenic Factors and Long-Term Cardiovascular Risk in Women That Developed Preeclampsia During Pregnancy	23
Longitudinal Changes of Input Impedance, Pulse Wave Velocity, and Wave Reflection in a Middle-Aged Population	23